Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Promising phase III trial results reported with Leuprogel three-month depot

July 11, 2001

Aventis transfers selected product rights to Introgen Therapeutics through investment

July 11, 2001

WHI-P131 useful for preventing colorectal cancer

July 11, 2001

Potential treatments for angiogenic disorders claimed by GSK company

July 10, 2001

Drop in disease progression on Casodex reported in prostate cancer trial

July 9, 2001

Licensing opportunity from NIH: novel antitumor macrocyclic lactones

July 9, 2001

Steroid sulfatase inhibitors in development by Novartis for cancer, etc.

July 6, 2001

Enzyme-inducing sulfenate and thiosulfinate esters described by U.S. university

July 6, 2001

WHI-P154 claimed for sensitizing cancer cells to radiation

July 6, 2001

Several series of antineoplastic agents presented by ADIR in patents

July 6, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...